Skip to main content
    H

    Harrow Health Inc (HROW)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.52
    +0.43 (+1.48%)

    Market Cap: $1.09B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Harrow Health Inc (HROW) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Harrow Health (HROW) has a market cap of $1.09B and an enterprise value of $1.32B. Revenue grew 21.28% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 20.66% above the market cap, as debt exceeds cash.

    Market Cap$1.09B
    Enterprise Value$1.32B
    Latest price (Nov 17, 2026)$29.52

    Key Dates

    The next earnings report is set for Mar 1, 2027, after the close.

    Next Earnings DateMar 1, 2027, after the close
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.41% in the quarter ended Sep 30, 2026 and grew 2.49% a year over 2 years.

    Shares Outstanding37.50M
    Shares Change (YoY)+0.96%
    Shares Change (QoQ)+0.41%
    Share Count Growth (2Y CAGR)+2.49%

    Valuation Ratios

    Sales and book value multiples are 3.7x and 37.9x. Its year-end P/S ranged from 1.3x to 6.6x from 2016 to 2025.

    P/S Ratio3.7x
    Forward P/S3.1x
    P/B Ratio37.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 58.1x EBITDA.

    EV / Sales4.3x
    EV / EBITDA58.1x

    Price Statistics

    The stock is down 27.63% over 52 weeks and trades 2.96% below its 50-day average.

    Beta (1Y)1.42
    52-Week Change-27.63%
    1-Month Change+6.65%
    3-Month Change-29.11%
    6-Month Change-3.78%
    5-Year Change+179.88%
    10-Year Change+951.77%
    Total Return (1Y)-27.63%
    Total Return (3Y CAGR)+48.79%
    Total Return (5Y CAGR)+22.31%
    Return vs SPY (1Y)-37.26%
    Max Drawdown (1Y)-52.48%
    Max Drawdown (3Y)-61.38%
    Sharpe Ratio (1Y)-0.45
    Correlation with SPY (1Y)0.30
    50-Day Average$30.42
    200-Day Average$37.37
    52-Week Range$25.76 to $54.85
    RSI (14 Days)51.0
    Average Volume (20 Days)697.73K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.29x current liabilities, and total debt is 10.31x shareholder equity.

    Current Ratio2.29x
    Quick Ratio2.12x
    Debt / Equity10.31x
    Debt / EBITDA13.11x
    Interest Coverage0.96x

    Returns and Efficiency

    Return on invested capital is -0.31% over the last 12 months, against a 5-year average of 2.13%.

    Return on Equity (ROE)-97.60%
    Return on Assets (ROA)-6.43%
    Return on Invested Capital (ROIC)-0.31%
    Return on Capital Employed (ROCE)-0.31%
    ROE (5Y Average)-56.00%
    ROA (5Y Average)-8.17%
    ROIC (5Y Average)2.13%
    Asset Turnover0.75x
    Inventory Turnover4.45x
    Receivables Turnover2.21x
    Cash Conversion Cycle98 days

    Scores

    HROW has an Altman Z-Score of 2.07, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score2.07
    Altman Z ZoneGrey
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $303.25M over the last 12 months.

    Revenue$303.25M
    Revenue Growth (YoY)+21.28%
    Gross Profit$222.94M
    Operating Income-$6.03M
    Pretax Income-$24.19M
    Net Income-$28.49M
    EBITDA$22.95M
    EBIT-$1.03M
    Reported EPS (TTM)-$0.69

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 6.59% of the $443.02M in total assets.

    Cash and Equivalents$75.34M
    Total Debt$300.86M
    Net Debt$225.52M
    Net Debt Per Share$6.01
    Working Capital$147.10M
    Shareholder Equity$29.19M
    Book Value Per Share$0.78
    Tangible Book Value-$142.50M
    Total Assets$443.02M
    Total Liabilities$414.19M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.40M of capital spending, operating cash flow left -$20.35M of free cash flow.

    Operating Cash Flow-$18.95M
    Capital Expenditures$1.40M
    Free Cash Flow-$20.35M
    FCF Per Share-$0.54
    Depreciation and Amortization$23.98M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1.99%, against a 5-year average of 4.07%.

    Gross Margin73.51%
    Operating Margin-1.99%
    Pretax Margin-7.98%
    Net Margin-9.39%
    EBITDA Margin7.57%
    EBIT Margin-0.34%
    FCF Margin-6.71%
    Gross Margin (5Y Average)73.23%
    Operating Margin (5Y Average)4.07%
    Net Margin (5Y Average)-14.03%

    Growth

    Revenue grew 45.39% a year over 3 years.

    Revenue Growth (3Y CAGR)+45.39%
    Revenue Growth (5Y CAGR)+40.99%
    Operating Income Growth (3Y CAGR)+151.47%
    Book Value Per Share Growth (2Y CAGR)-15.57%

    Revenue and profit by year

    Dividends and Yields

    HROW does not pay a dividend. Its free cash flow yield is -1.84%.

    FCF Yield-1.84%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-5 reverse split on Feb 8, 2013.

    Last Split DateFeb 8, 2013
    Split TypeReverse split
    Split Ratio1:5

    Peer Position

    Against 12 similar companies, HROW has the 2nd highest P/S.

    P/S Ratio3.7x vs 1.8x median
    ROIC-0.31% vs 7.08% median
    Revenue Growth (Trailing 4 Quarters, YoY)+21.28% vs +10.45% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 38.72% and EPS growth at 102.17% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+38.72%
    EPS Growth Forecast (2Y CAGR)+102.17%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HROW

    What is HROW's market cap?

    Harrow Health has a market cap of $1.09B. Its enterprise value, which adds debt and subtracts cash, is $1.32B.

    How many shares of HROW are outstanding?

    Harrow Health has 37.50M shares outstanding. The count is up 0.96% from a year earlier.

    Does HROW pay a dividend?

    No. Harrow Health does not pay a dividend.

    How much debt does HROW have?

    Harrow Health has $300.86M of total debt and $75.34M of cash and equivalents, a net debt position of $225.52M.